Afyxtx
Hørsholm, DK · 1 known investors
Find your way into Afyxtx
AFYX is a biopharmaceutical company focused on reformulation and repurposing of existing pharmaceuticals for conditions including head and neck cancer, labor induction, cluster headaches, and pain and addiction. The company operates across 46 global markets through direct operations and partnerships.
Founders & leadership
DC
Dr. Claus J. Møller-San PedroCEO
Investors · 1
Competitors · 4
by search overlapBioworld6 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Exelixis6 shared keywordsExelixis is an oncology company that discovers and develops cancer treatments, including small molecule therapeutics and biotherapeutics such as antibody-drug conjugates, for patients across multiple tumor types. Its flagship commercial product is CABOMETYX (cabozantinib), and it operates through global development and commercialization partnerships.
Ultragenyx4 shared keywordsUltragenyx is a biotechnology company focused on developing treatments for patients living with rare genetic diseases. The company emphasizes a culture of generosity, curiosity, and inclusion among its team members.
Simply Wall St3 shared keywordsSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
Companies competing with Afyxtx for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Afyxtx do?
- AFYX is a biopharmaceutical company focused on reformulation and repurposing of existing pharmaceuticals for conditions including head and neck cancer, labor induction, cluster headaches, and pain and addiction. The company operates across 46 global markets through direct operations and partnerships.
- Who are Afyxtx's investors?
- Afyxtx's investors include Sofinnova Ventures.
- Where is Afyxtx headquartered?
- Afyxtx is headquartered in Hørsholm, DK.